NANJING, China--(BUSINESS WIRE)--Sorin Group, (MIL:SRN) (Reuters Code: SORN.MI), a global medical device company and a leader in the treatment of cardiovascular diseases, announces today the marketing ...
MILAN--(BUSINESS WIRE)--Sorin Group (MIL:SRN), (Reuters Code: SORN.MI), a global medical company and a leader in the treatment of cardiovascular diseases, announced today CE mark approval and the ...
The Sorin Group (MIL:SRN), the largest European cardiovascular company and world leader in medical technologies for cardiac surgery, announced today the U.S. Food and Drug Administration´s (FDA) ...
Results from SORIN GROUP’s long-term clinical randomized trial showed that the SafeR pacing mode significantly reduces heart failure events (death and hospitalization) Nice, France, – Sorin Group, a ...
Italy's Sorin Group, inventors of an 8cc pacemaker called REPLY, reports that it's now successfully being implanted into patients. Not only is it tiny, but it uses a proprietary method for pacing, ...
Italy's Sorin says revenue grew slightly at the end of its 2013 second quarter as the cardiac device company began to shake off the effects of an earthquake from the previous year. Still, pacemaker ...
Sorin Group gained the FDA's backing to begin a U.S. clinical trial for its new sutureless aortic tissue valve. This is a major win for the Italian cardiac device giant as it pushes to diversify its ...
ELA Medical, a subsidiary of Italian medical device maker Sorin Group, reaches a tentative, $10 million settlement with the U.S. Justice Dept. over charges that it ran a kickbacks scheme to drive ...
Reportbuyer.com has added a new market research report: TechNavio's analysts forecast the Global Cardiac Pacemakers market will grow at a CAGR of 13.83 percent over the period 2013-2018. One of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback